MINUTES
About Minutes
Back to latest

HealthFDA warns of vision-loss risk linked to popular GLP-1 drugs such as Wegovy and Zepbound

The FDA says it has found evidence of a potential increase in the risk of a rare eye condition associated with GLP-1 drugs used for weight management and diabetes, including drugs such as Wegovy and Zepbound.

FDAGLP-1 drugsvision lossdrug safety

CCNBC★★★☆☆2026-11-10 07:52Original

FDA warns of vision-loss risk linked to popular GLP-1 drugs such as Wegovy and Zepbound
FDA warns of vision-loss risk linked to popular GLP-1 drugs such as Wegovy and ZepboundHealth